Literature DB >> 17906295

Green tea consumption and prostate cancer risk in Japanese men: a prospective study.

Norie Kurahashi1, Shizuka Sasazuki, Motoki Iwasaki, Manami Inoue, Shoichiro Tsugane.   

Abstract

The incidence of prostate cancer is much lower in Asian than Western populations. Given that environmental factors such as dietary habits may play a major role in the causation of prostate cancer and the high consumption of green tea in Asian populations, this low incidence may be partly due to the effects of green tea. The JPHC Study (Japan Public Health Center-based Prospective Study) was established in 1990 for cohort I and in 1993 for cohort II. The subjects were 49,920 men aged 40-69 years who completed a questionnaire that included their green tea consumption habit at baseline and were followed until the end of 2004. During this time, 404 men were newly diagnosed with prostate cancer, of whom 114 had advanced cases, 271 were localized, and 19 were of an undetermined stage. Green tea was not associated with localized prostate cancer. However, consumption was associated with a dose-dependent decrease in the risk of advanced prostate cancer. The multivariate relative risk was 0.52 (95% confidence interval: 0.28, 0.96) for men drinking 5 or more cups/day compared with less than 1 cup/day (p(trend) = 0.01). Green tea may be associated with a decreased risk of advanced prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906295     DOI: 10.1093/aje/kwm249

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  90 in total

1.  Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention.

Authors:  Piwen Wang; William J Aronson; Min Huang; Yanjun Zhang; Ru-Po Lee; David Heber; Susanne M Henning
Journal:  Cancer Prev Res (Phila)       Date:  2010-07-13

Review 2.  Tea and health: preventive and therapeutic usefulness in the elderly?

Authors:  Bradley W Bolling; Chung-Yen Oliver Chen; Jeffrey B Blumberg
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2009-01       Impact factor: 4.294

Review 3.  The strategies to control prostate cancer by chemoprevention approaches.

Authors:  Harold Ting; Gagan Deep; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-01-02       Impact factor: 2.433

4.  Epigallocatechin-3-gallate regulates the expression of Kruppel-like factor 4 through myocyte enhancer factor 2A.

Authors:  Yuwen Ma; Youkui Shi; Wenmei Li; Aijuan Sun; Ping Zang; Peirong Zhang
Journal:  Cell Stress Chaperones       Date:  2013-07-25       Impact factor: 3.667

Review 5.  Tea and human health: biomedical functions of tea active components and current issues.

Authors:  Zong-mao Chen; Zhi Lin
Journal:  J Zhejiang Univ Sci B       Date:  2015-02       Impact factor: 3.066

6.  Cancer prevention by green tea: evidence from epidemiologic studies.

Authors:  Jian-Min Yuan
Journal:  Am J Clin Nutr       Date:  2013-10-30       Impact factor: 7.045

7.  Plasma 25-hydroxy vitamin D and subsequent prostate cancer risk in a nested Case-Control study in Japan: The JPHC study.

Authors:  N Sawada; M Inoue; M Iwasaki; T Yamaji; T Shimazu; S Sasazuki; S Tsugane
Journal:  Eur J Clin Nutr       Date:  2016-10-19       Impact factor: 4.016

8.  Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.

Authors:  Shumei Song; Koyamangalath Krishnan; Kaifeng Liu; Robert S Bresalier
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

Review 9.  Green tea polyphenols for prostate cancer chemoprevention: a translational perspective.

Authors:  J J Johnson; H H Bailey; H Mukhtar
Journal:  Phytomedicine       Date:  2010-01       Impact factor: 5.340

Review 10.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.